Howard-GeorgeProfessor and Chair

Dept. of Biostatistics
School of Public Health

Contact Information:

Office Address: RPHB 327
Phone: 205-934-4554
Websites: Dept. of Biostatistics Faculty Page


St. Andrews Presbyterian College, Laurinburg, NC 
BA, Math and Business, 1973

University of North Carolina at Chapel Hill 
MS, Operations Research, 1976

University of North Carolina at Greensboro, NC 
MBA, Finance and Marketing, 1979

University of North Carolina at Chapel Hill 
MSPH, Biostatistics, 1982

University of North Carolina at Chapel Hill
DrPH, Biostatistics, 1987

Research Description:

Dr. George Howard is Professor and Chair of Biostatistics at the UAB. He received his training in biostatistics was from the University of North Carolina at Chapel Hill. He has had experience in biostatistics, data management, and the direction of coordinating centers of multicenter studies. He is currently the overall project PI for the REasons for Geographic and Racial Differences in Stroke (REGARDS) project, a national study developing a cohort of 30,000 individuals to provide insights to the excess stroke mortality among African Americans and Southerners.  Having mentored junior faculty to the point where they could assume the Principal Investigator position from him, he is the immediate past PI of the Coordinating Centers the Carotid Revascularization Endarterectomy Stenting Trial (CREST), Secondary Prevention of Small Subcortical Strokes (SPS3), and the Trial of Early Aggressive Treatment of Rheumatoid Arthritis (TEAR) Trial – all studies still underway under the leadership of faculty in Biostatistics and Epidemiology.  He was previously the PI of the Coordinating Center for the Insulin Resistance Atherosclerosis Study (IRAS), the Autoimmune Ear Disease (AIED) Study, the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT), and as Co-PI in the Southeastern Consortium on Racial Differences in Stroke (SECORDS).  He has been a co-investigator in numerous epidemiological studies and clinical trials including Atherosclerosis Risk in Communities (ARIC), the Community Hospital-Based Stroke Program, the Postmenopausal Estrogen/Progestin Interventions (PEPI) study, and the Asymptomatic Carotid Atherosclerosis Study (ACAS).  He has published extensively in the analysis of cardiovascular and cerebrovascular risk factors, and has nearly 30 years experience working directly with clinical investigators.


DRC Membership Category:

Senior Scientist